Cargando…
Minocycline for the treatment of mental health and neurological conditions: study protocol of a systematic review and meta-analysis
INTRODUCTION: Due to the anti-inflammatory, antioxidant and anti-apoptotic properties of minocycline, clinical trials have evaluated the potential of this drug to treat several psychiatric and neurological disorders, including major depressive disorder, schizophrenia, bipolar disorder, stroke and am...
Autores principales: | Bortolasci, Chiara C, Marx, Wolfgang, Walker, Adam J, Hasebe, Kyoko, Kavanagh, Bianca E, Morris, Margaret J, Mohebbi, Mohammadreza, Turner, Alyna, Gray, Laura, Berk, Lesley, Walder, Ken, Berk, Michael, Dean, Olivia M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103827/ https://www.ncbi.nlm.nih.gov/pubmed/32198305 http://dx.doi.org/10.1136/bmjopen-2019-035080 |
Ejemplares similares
-
Minocycline as Treatment for Psychiatric and Neurological Conditions: A Systematic Review and Meta-Analysis
por: Panizzutti, Bruna, et al.
Publicado: (2023) -
Adjunctive minocycline for major depressive disorder: A sub-study exploring peripheral immune-inflammatory markers and associated treatment response
por: Walker, Adam J., et al.
Publicado: (2022) -
Mechanisms Underpinning the Polypharmacy Effects of Medications in Psychiatry
por: Bortolasci, Chiara C, et al.
Publicado: (2018) -
Personality disorder and functioning in major depressive disorder: a nested study within a randomized controlled trial
por: Kavanagh, Bianca E., et al.
Publicado: (2019) -
The Effect of Adjunctive Mangosteen Pericarp on Cognition in People With Schizophrenia: Secondary Analysis of a Randomized Controlled Trial
por: Marx, Wolfgang, et al.
Publicado: (2021)